154 related articles for article (PubMed ID: 34004186)
1. Translating inspiration from COVID-19 vaccine trials to innovations in clinical cancer research.
Choudhury NJ; Riely GJ; Sabbatini PJ; Hellmann MD
Cancer Cell; 2021 Jul; 39(7):897-899. PubMed ID: 34004186
[No Abstract] [Full Text] [Related]
2. COVID-19 vaccines and treatments: When speed is necessary and not enough.
Grasela TH; Price DA; Wagner JA
Clin Transl Sci; 2021 Jul; 14(4):1201-1205. PubMed ID: 33834614
[No Abstract] [Full Text] [Related]
3. An update on the global vaccine development for coronavirus.
Rab S; Afjal ; Javaid M; Haleem A; Vaishya R
Diabetes Metab Syndr; 2020; 14(6):2053-2055. PubMed ID: 33113472
[No Abstract] [Full Text] [Related]
4. SARS-CoV-2 vaccines for cancer patients: a call to action.
Corti C; Crimini E; Tarantino P; Pravettoni G; Eggermont AMM; Delaloge S; Curigliano G
Eur J Cancer; 2021 May; 148():316-327. PubMed ID: 33770576
[TBL] [Abstract][Full Text] [Related]
5. Accelerating vaccine trials.
Bull World Health Organ; 2021 Jul; 99(7):482-483. PubMed ID: 34248219
[TBL] [Abstract][Full Text] [Related]
6. [COVID-19: Warp Speed vaccines].
Feraoun Y; Maisonnasse P; Le Grand R; Beignon AS
Med Sci (Paris); 2021; 37(8-9):759-772. PubMed ID: 34080537
[TBL] [Abstract][Full Text] [Related]
7. Emer Cooke.
Mullard A
Nat Rev Drug Discov; 2021 Jan; 20(1):12-13. PubMed ID: 33311579
[No Abstract] [Full Text] [Related]
8. Assessing the Safety of COVID-19 Vaccines: A Primer.
Petousis-Harris H
Drug Saf; 2020 Dec; 43(12):1205-1210. PubMed ID: 32997318
[TBL] [Abstract][Full Text] [Related]
9. China's vaccine gambit.
Cohen J
Science; 2020 Dec; 370(6522):1263-1267. PubMed ID: 33303601
[No Abstract] [Full Text] [Related]
10. Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.
Saadeldin MK; Abdel-Aziz AK; Abdellatif A
Med Hypotheses; 2021 Jan; 146():110365. PubMed ID: 33221134
[TBL] [Abstract][Full Text] [Related]
11. [Lightning fast development of pandemic vaccines in 2020].
Josefsdottir KS
Laeknabladid; 2020 Dec; 106(12):567. PubMed ID: 33252047
[No Abstract] [Full Text] [Related]
12. Opinion: For now, it's unethical to use human challenge studies for SARS-CoV-2 vaccine development.
Kahn JP; Henry LM; Mastroianni AC; Chen WH; Macklin R
Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28538-28542. PubMed ID: 33122444
[No Abstract] [Full Text] [Related]
13. The story behind COVID-19 vaccines.
Fauci AS
Science; 2021 Apr; 372(6538):109. PubMed ID: 33833099
[No Abstract] [Full Text] [Related]
14. A review of COVID-19 vaccines in development: 6 months into the pandemic.
Sanicas M; Sanicas M; Diop D; Montomoli E
Pan Afr Med J; 2020; 37():124. PubMed ID: 33425157
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development.
Ita K
Arch Med Res; 2021 Jan; 52(1):15-24. PubMed ID: 32950264
[TBL] [Abstract][Full Text] [Related]
16. The Need for Novel Approaches in Assessing the Value of COVID-19 Vaccines.
Angelis A; Baltussen R; Tervonen T
Am J Public Health; 2021 Feb; 111(2):205-208. PubMed ID: 33439703
[No Abstract] [Full Text] [Related]
17. IABS/CEPI platform technology webinar: Is it possible to reduce the vaccine development time?
Vandeputte J; Saville M; Cavaleri M; Friede M; Hacker A; Mueller SO; Rizzi R; Smith D; Thirstrup S; Wagner R; Baay M; Neels P
Biologicals; 2021 Jun; 71():55-60. PubMed ID: 33966960
[TBL] [Abstract][Full Text] [Related]
18. Science and Evidence-Based Review and Approval of COVID-19 Vaccines: A Statement of Support for the US FDA.
Pai SM; Othman AA; Rusch L; Masters JC; Greene D; Rogge M; Gries JM; Clementi W; Kumar P; Younis I; Salem AH; Gaynes BI; Pastino G; Derendorf H;
J Clin Pharmacol; 2021 Mar; 61(3):277-279. PubMed ID: 33274473
[No Abstract] [Full Text] [Related]
19. COVID-19 vaccine effectiveness in patients with cancer: remaining vulnerabilities and uncertainties.
Kuderer NM; Lyman GH
Lancet Oncol; 2022 Jun; 23(6):693-695. PubMed ID: 35617990
[No Abstract] [Full Text] [Related]
20. Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine.
Milane L; Amiji M
Drug Deliv Transl Res; 2021 Aug; 11(4):1309-1315. PubMed ID: 33512669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
